BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND LDH AND Treatment
95 results:

  • 1. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma.
    Burkhard-Meier A; Jurinovic V; Berclaz LM; Albertsmeier M; Dürr HR; Klein A; Knösel T; Di Gioia D; Unterrainer LM; Schmidt-Hegemann NS; Ricke J; von Bergwelt-Baildon M; Kunz WG; Lindner LH
    Clin Exp Metastasis; 2024 Apr; 41(2):131-141. PubMed ID: 38421522
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
    Chen W; Ye M; Sun Y; Wei Y; Huang Y
    Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells.
    Yang J; Jiang H; Fu Q; Qin H; Li Y; Liu M
    J Photochem Photobiol B; 2023 Dec; 249():112814. PubMed ID: 37956614
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes in patients with
    Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto PA; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
    Tumori; 2023 Dec; 109(6):537-545. PubMed ID: 37417313
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Effects of fucoidan inducing impairment of human osteosarcoma cell 143B and its mechanism].
    Wang QQ; Lin Q; Shan WY; Zhang T; Li YR; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):739-744. PubMed ID: 37308428
    [No Abstract]    [Full Text] [Related]  

  • 6. Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.
    Stadler JC; Keller L; Mess C; Bauer AT; Koett J; Geidel G; Heidrich I; Vidal-Y-Sy S; Andreas A; Stramaglia C; Sementsov M; Haberstroh W; Deitert B; Hoehne IL; Reschke R; Haalck T; Pantel K; Gebhardt C; Schneider SW
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258039
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study.
    Chen K; Xu J; Wang W; Jiang R; Zhang H; Wang X; Cao J; Fang M
    Cancer Med; 2023 May; 12(10):11363-11374. PubMed ID: 37081723
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Relaxin inhibits
    Xu J; Wan S; Chen W; Zhang Y; Ji Z
    Acta Pharm; 2022 Dec; 72(4):575-585. PubMed ID: 36651368
    [No Abstract]    [Full Text] [Related]  

  • 9. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
    Lo WL; Huang WH; Yeh CF
    In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
    Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
    Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
    Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
    Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel computer aided diagnostic models on multimodality medical images to differentiate well differentiated liposarcomas from lipomas approached by deep learning methods.
    Yang Y; Zhou Y; Zhou C; Ma X
    Orphanet J Rare Dis; 2022 Apr; 17(1):158. PubMed ID: 35392952
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF
    Robert C; Lewis KD; Gutzmer R; Stroyakovskiy D; Gogas H; Protsenko S; Pereira RP; Eigentler T; Rutkowski P; Demidov L; Caro I; Forbes H; Shah K; Yan Y; Li H; McArthur GA; Ascierto PA
    Ann Oncol; 2022 May; 33(5):544-555. PubMed ID: 35131452
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
    Erdogan B; Kostek O; Bekir Hacioglu M; Gokyer A; Kucukarda A; Ozcan E; Gokmen I; Uzunoglu S; Cicin I
    J BUON; 2021; 26(5):2196-2201. PubMed ID: 34761635
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
    Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto P; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
    Target Oncol; 2021 Nov; 16(6):789-799. PubMed ID: 34755244
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
    Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
    Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma.
    Cybulska-Stopa B; Ziętek M; Czarnecka AM; Piejko K; Dziura R; Galus Ł; Ziółkowska B; Kieszko S; Kempa-Kamińska N; Calik J; Seredyńska J; Gądek K; Zemełka T; Teterycz P; Kubiatowski T; Suwiński R; Mackiewicz J; Rutkowski P
    J Dermatolog Treat; 2022 Jun; 33(4):2168-2174. PubMed ID: 34057374
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Venous Tumor Thrombus in Primary Bone sarcomas in the Pelvis: A Clinical and Radiographic Study of 451 Cases.
    Liang H; Guo W; Tang X; Yang R; Yan T; Yang Y; Ji T; Sun X; Xie L; Xu J
    J Bone Joint Surg Am; 2021 Aug; 103(16):1510-1520. PubMed ID: 33857031
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Comparison of Osseous and Extraosseous Ewing Sarcoma.
    Esen SA; Acikgoz Y; Bal O; Yildiz B; Ucar G; Dirikoc M; Ergun Y; Algin E; Uncu D
    J Coll Physicians Surg Pak; 2021 Jan; 31(1):27-33. PubMed ID: 33546529
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
    Sarkhosh-Inanlou R; Imani M; Sam MR
    Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.